| Literature DB >> 30563471 |
Elke Hausner1, Maria-Inti Metzendorf2, Bernd Richter2, Fabian Lotz3, Siw Waffenschmidt4.
Abstract
BACKGROUND: Little evidence is available on searches for non-randomized studies (NRS) in bibliographic databases within the framework of systematic reviews. For instance, it is currently unclear whether, when searching for NRS, effective restriction of the search strategy to certain study types is possible. The following challenges need to be considered: 1) For non-randomized controlled trials (NRCTs): whether they can be identified by established filters for randomized controlled trials (RCTs). 2) For other NRS types (such as cohort studies): whether study filters exist for each study type and, if so, which performance measures they have. The aims of the present analysis were to identify and validate existing NRS filters in MEDLINE as well as to evaluate established RCT filters using a set of MEDLINE citations.Entities:
Keywords: Databases, bibliographic; Information storage and retrieval; Medline; Reproducibility of results; Sensitivity and specificity
Mesh:
Year: 2018 PMID: 30563471 PMCID: PMC6299552 DOI: 10.1186/s12874-018-0625-4
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Study types extracted
| Coding | Terms (following Hartling et al. [ |
|---|---|
| 1 | Randomized controlled trial (RCT) |
| 2 | Non-randomized controlled trial (NRCT)a) |
| 3 | Controlled before-after study |
| 4 | Interrupted time series (with comparison group) |
| 5 | Prospective cohort study |
| 6 | Retrospective cohort study |
| 7 | Non-concurrent cohort study |
| 8 | (Nested) case-control study |
| 9 | Cross-sectional study |
| 10 | Non-comparative study (e.g. case report or case series) |
| 11 | Before-after study |
| 12 | Interrupted time series (without comparison group) |
a)Also refers to quasi-randomized controlled trial and controlled clinical trial
Fig. 1Flowchart for generation of the test sets
Inclusion criteria for Cochrane reviews (after abstract screening)
| Inclusion criteria | |
|---|---|
| I1a | Most current version of a Cochrane review |
| I2a | A Cochrane review evaluating an intervention on a health-related question (e.g. can also include topics from the field of public health) |
| I3a | A Cochrane review not only including RCTs or NRCT |
| I4a | A Cochrane review including NRS (based on the section “Main results” of the abstract of the Cochrane review) |
| I5a | A Cochrane review including < 65 studies |
Characteristics of the reference set
| Study type | Number of CRsa) | Number of studies | Number of PMIDsb) |
|---|---|---|---|
| Randomized controlled trial | 183 | 1471 | 1598 |
| Nonrandomized controlled trial | 67 | 216 | 331 |
| Controlled before-after study | 104 | 634 | 556 |
| Interrupted time series (with comparison group) | 31 | 83 | 106 |
| Prospective cohort study | 84 | 384 | 435 |
| Retrospective cohort study | 72 | 436 | 451 |
| Non-concurrent cohort study | 13 | 34 | 31 |
| (Nested) case-control study | 36 | 207 | 200 |
| Cross-sectional study | 17 | 152 | 136 |
| Non-comparative study (case report or case series) | 22 | 249 | 226 |
| Before-after study | 41 | 257 | 239 |
| Interrupted time series (without comparison group) | 45 | 221 | 179 |
| Study type unclear | 42 | 138 | 56 |
|
|
|
| 4544 |
a)Number of CRs in which the study type was included at least once (multiple counting possible)
b)Without duplicates
Fig. 2Type of intervention examined by Cochrane reviews in the reference set (according to Polus et al. [9])
Overview and evaluation of the NRS filters identified
| Study filters (developers) | Study types targeted | Codinga) | Hits in MEDLINE | Sensitivity (interval)b) |
|---|---|---|---|---|
| Clinical trials (University of Texas) [ | Clinical trials | 2 | 1.445.276 | 39% |
| Observational Studies – Medline (SIGN) [ | Observational studies | 5–10 | 2.492.125 | 49–90% |
| MEDLINE precision (Fraser 2000) [ | Observational studies | 5–8,10 | 9.509.757 | 73–88% |
| MEDLINE specificity (Fraser 2000) [ | Observational studies | 5–8,10 | 8.423.107 | 53–85% |
| MEDLINE cohort, case-control, and case series strategy (BMJ) [ | Observational studies | 5–8,10 | 2.517.309 | 55–92% |
| MEDLINE cohort, case-control, case series, and case study strategy (BMJ) [ | Observational studies | 5–8,10 | 4.441.461 | 61–93% |
| Search terms for finding non-RCTs (Royle 2003) [ | Non-RCT | 2–12 | 8.073.091 | 46–98% |
| MEDLINE cohort study strategy (BMJ) [ | Cohort studies | 5–7 | 1.982.782 | 58–69% |
| Cohort studies (University of Texas) [ | Cohort studies | 5–7 | 2.204.911 | 52–72% |
| Case-control studies_1 (University of Texas) [ | Case-control studies | 8 | 660.864 | 78% |
| Case-control studies_2 (University of Texas) [ | Case-control studies | 8 | 1.284.387 | 80% |
| Medline cohort and case-control strategy (BMJ) [ | Cohort, case-control | 5–8 | 2.430.887 | 61–92% |
| Fixed method A for MEDLINE (Furlan 2006) [ | Cohort, case-control, cross-sectional | 5–9 | 4.184.894 | 49–83% |
| Fixed method B for MEDLINE (Furlan 2006) [ | Cohort, case-control, cross-sectional | 5–9 | 6.559.073 | 69–85% |
a) Coding of study types; see Table 2; b) Presentation as an interval if the study filter covers more than one study type
SIGN Scottish Intercollegiate Guidelines Network, BMJ British Medical Journal Clinical Evidence
Evaluation of established RCT filters
| Study filters | Hits in MEDLINE | Sensitivity NRCTs |
|---|---|---|
| Therapy Medline (Haynes 2005) – max. Sensitivity | 5.213.988 | 54% |
| Therapy Medline (Haynes 2005) – max. Specifity | 485.918 | 13% |
| Therapy Medline (Haynes 2005) – optimizing sensitivity/specifity | 796.127 | 16% |
| Cochrane Search Strategy (2008) – sensitivity-max. | 3.581.596 | 57% |
| Cochrane Search Strategy (2008) – sensitivity and precision-max. | 1.057.717 | 37% |